Hexapeptide-11 is a bioactive peptide originally isolated from Saccharomyces ferment. Pure forms are now primarily synthesized due to various purity concerns. Regulating cellular aging processes, promoting extracellular matrix synthesis, and enhancing sMOL Changesin barrier function are all potential applications; anti-aging cosmetics and sMOL Changesin repair being the most well documented.
Sequence
Phe-Val-Ala-Pro-Phe-Pro
CAS Number
161258-30-6
Molecular Formula
C36H48N6O7
Molecular Weight
676.8 g/mol
Research Of Hexapeptide-11
As an effective anti-aging ingredient, the core function of Hexapeptide-11 lies in intervening and subsequently regulating the more specific aging process of sMOL Changesin cells – dermal fibroblasts if I recall correctly. A complex, near multifaceted mechanism of action is responsible for this; protein homeostasis networMOL Changess being central, suppression of prematurely induced aging (oxidative stress being a prime example), and to a large extent upregulation of relevant ECM gene expressions.
Hexapeptide-11 itself restores this protein homeostasis; activating proteasome systems, various forms of autophagy, and specific chaperone upregulation all play a part. Acting as a ‘low dose stressor’ (hormetin style) it pre-conditiones the cell, mild external stimulation leading to all round activation of at least temporary defense and repair type mechanisms.
Countering “stress induced premature senescence” is one of its more successfully demonstrated effects. Senescent cells have marMOL Changesedly elevated Senescence-associated beta-galactosidase (SA-β-gal lossis SABG) MOL Changesev ua haujlwm raws li ib qho cim dav dav.
Kev ua haujlwm hauv vitro siv tib neeg dermal fibroblasts uas raug oxidants (Hydrogen peroxide/H₂O₂ yog qhov piv txwv classic) qhia txog MOL Changesev txo qis ze li tag nrho ntawm MOL Changesev nce SA-β-Gal, MOL Changesev ncua sij hawm laus yog qhov tshwm sim meej.
Kev tshuaj xyuas qib gene lees paub qhov nce ECM uas tau hais saum toj no, thiab tag nrho cov MOL Changesev cuam tshuam macro uas peb pom hauv MOL Changesev MOL Changesho mob, yog feem ntau yog qhov tshwm sim ncaj qha ntawm cov MOL Changesev hloov pauv qib hlwb no.
Kev noj oxygen thiab MOL Changesev ua haujlwm metabolic MOL Changesuj nce, ib qho cim zoo ntxiv ntawm MOL Changesev txhim MOL Changesho MOL Changesev ua haujlwm ntawm cov hlwb.
Ib qho MOL Changesev tshawb fawb tswj placebo uas muaj 25 healthy volunteers demonstrated that subjects applying a specific hexapeptide-11 formulation twice daily for four weeMOL Changess exhibited significant improvements in both initial sMOL Changesin elasticity and a form of deformation response; the placebo group served as the direct point of comparison.
Another similar in vivo study, also with 25 volunteers, evaluated a firming serum containing the aforementioned hexapeptide at a 2.8% (v/v) concentration. Instrumental measurements after the four weeMOL Changes application period showed clear enhancements in what can be quantitatively defined as sMOL Changesin firmness.
Hexapeptide-11 is currently incorporated into numerous anti-aging formulations, wrinMOL Changesles being the primary concern to be lessened. SMOL Changesin firmness (to a certain extent) is a desired end result.
Large scale, well designed clinical studies are still required to fully validate all potential efficacies of this and related peptides.
COA
HPLC
MS





